Human Immunodeficiency Virus
Conditions
Keywords
HIV, Telemedicine, Substance use
Brief summary
This study called Peers plus mobile App for Treatment in HIV (PATH) is a two-arm randomized controlled trial (RCT) evaluating the efficacy of an intervention that combines peer navigation and mobile health (mHealth) technology to support HIV care outcomes among Hispanic and Black Persons Living with HIV (HBPLH).
Detailed description
PATH is a community-academic collaboration with a federally qualified health center serving patients in South San Diego under the Ryan White model of care. The scientific premise of this RCT is that combining two interventions developed by this team (peer navigation + mHealth) into a single mHealth peer navigation intervention (PATH) will eliminate the need for in-person support from peer navigators, promote high impact on HIV care continuum outcomes, as well as extend broader reach to underserved communities. The RCT will test the efficacy of PATH with 375 HBPLH (among whom \>33% will report stimulant and/or opioid use in the past 6 months). Aim 1. Improve the primary outcomes - sustained viral suppression (i.e., suppressed viral load at both 6- and 12-month follow-up), and secondary outcomes (e.g., retention in care) compared to usual care. Sub-aim 1: Explore subgroup differences in efficacy based on factors like race/ethnicity and substance use. Aim 2. Examine the theory-informed mediators (e.g., self-efficacy to engage in HIV care, HIV stigma) through which PATH has the greatest impact on sustained viral suppression among HBPLH. Aim 3. Explore whether PATH significantly affects substance-related outcomes (e.g., frequency of substance use, engagement in substance abuse treatment) when compared to usual care among those using substances (i.e., stimulants and/or opioids).
Interventions
BEHAVIORALPATH
The intervention integrates two theoretically-grounded interventions - one with a strong peer navigator component and the other with a scalable mHealth component - into the intervention called Peers plus mobile App for Treatment in HIV (PATH)
Sponsors
San Diego State University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* ≥18 years old * Can read and speak English or Spanish * Self-reported diagnosis of HIV by a physician or healthcare provider * Currently prescribed HIV medication * Having access to an internet browser on a home computer, tablet, or smart phone * Does not plan to move out of the San Diego area in the next 12 months * Meets one or more of the following medical chart verified or self-reported criteria * One or more detectable viral load test result (\>200 copies m/L) in the past 12-months while on antiretroviral therapy for at least 3 months * Having missed 1 or more scheduled HIV care appointments in the last 12 months * Last HIV care visit was more than 6 months ago * Self-reporting less than 90% antiretroviral therapy adherence in the last 4 weeks using the Wilson-3 scale * Report stimulant or opioid use (non-prescription) in the past 6 months
Exclusion criteria
* \<18 years old * Currently enrolled in any program, intervention, or research study designed to improve antiretroviral therapy adherence or engagement in HIV care (e.g., LinkPositively) * Members of one of the community advisory boards providing advisement on the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Viral suppression | 6 months | Having an undetectable HIV viral load; \<200 copies/mL |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Retention in HIV care | 6 months | Health Resources and Services Administration definition: ≥ 2 HIV medical visits at least 90 days apart |
| Gap in HIV medical visits | 6 months | Health Resources and Services Administration definition: no HIV medical visits in last 6 months |
| Antiretroviral therapy adherence | 3 months | Continuous measure of antiretroviral therapy adherence using the Wilson's three-item Adherence Self-Report Scale scale (0-100; 100=perfect adherence) |
Countries
United States
Outcome results
None listed